- Home
- IMCR vs TNC Comparison
IMCR vs TNC Comparison
Compare IMCR & TNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- TNC
- Stock Information
- Founded
- IMCR 2008
- TNC 1870
- Country
- IMCR United Kingdom
- TNC United States
- Employees
- IMCR N/A
- TNC N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- TNC Industrial Machinery/Components
- Sector
- IMCR Health Care
- TNC Industrials
- Exchange
- IMCR Nasdaq
- TNC Nasdaq
- Market Cap
- IMCR 1.8B
- TNC 1.5B
- IPO Year
- IMCR 2021
- TNC N/A
- Fundamental
- Price
- IMCR $34.42
- TNC $81.15
- Analyst Decision
- IMCR Buy
- TNC Strong Buy
- Analyst Count
- IMCR 8
- TNC 1
- Target Price
- IMCR $57.00
- TNC $125.00
- AVG Volume (30 Days)
- IMCR 275.9K
- TNC 98.0K
- Earning Date
- IMCR 11-05-2025
- TNC 10-30-2025
- Dividend Yield
- IMCR N/A
- TNC 1.45%
- EPS Growth
- IMCR N/A
- TNC N/A
- EPS
- IMCR N/A
- TNC 3.20
- Revenue
- IMCR $356,145,000.00
- TNC $1,253,300,000.00
- Revenue This Year
- IMCR $31.83
- TNC N/A
- Revenue Next Year
- IMCR $8.50
- TNC $3.88
- P/E Ratio
- IMCR N/A
- TNC $25.36
- Revenue Growth
- IMCR 26.78
- TNC N/A
- 52 Week Low
- IMCR $23.15
- TNC $67.32
- 52 Week High
- IMCR $39.33
- TNC $98.52
- Technical
- Relative Strength Index (RSI)
- IMCR 50.65
- TNC 47.61
- Support Level
- IMCR $35.33
- TNC $80.89
- Resistance Level
- IMCR $36.76
- TNC $83.12
- Average True Range (ATR)
- IMCR 1.36
- TNC 1.73
- MACD
- IMCR 0.16
- TNC -0.16
- Stochastic Oscillator
- IMCR 40.47
- TNC 37.53
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About TNC Tennant Company
Tennant Co is a manufacturer of floor cleaning equipment, wood flooring, and wood products. It operates in four geographic business units including North America; Latin America; Europe, Middle East, Africa; and Asia Pacific. The company offers products and solutions consisting of mechanized cleaning equipment, detergent-free, and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, specialty surface coatings, and business solutions such as financing, rental and leasing programs, and machine-to-machine asset management solutions.